Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages
Mélanie Tichet(Ludwig Cancer Research), Douglas Hanahan(Ludwig Cancer Research)
Cited by 127
Related Papers
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
|Cancer Cell|2012|4.7k
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
|Cancer Cell|2005|1.6k
Plasmid screening at high colony density
|Gene|1980|1.1k